Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
QuintilesIMS
Fuji
Express Scripts
Baxter
Boehringer Ingelheim
Argus Health
Cipla
Medtronic
Moodys

Generated: February 24, 2018

DrugPatentWatch Database Preview

Chlorpheniramine polistirex; codeine polistirex - Generic Drug Details

« Back to Dashboard

What are the generic sources for chlorpheniramine polistirex; codeine polistirex and what is the scope of chlorpheniramine polistirex; codeine polistirex patent protection?

Chlorpheniramine polistirex; codeine polistirex
is the generic ingredient in three branded drugs marketed by Ucb Inc, Fisons, and Vernalis R And D Ltd, and is included in three NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Chlorpheniramine polistirex; codeine polistirex has twenty-one patent family members in fourteen countries.

There are twenty-nine drug master file entries for chlorpheniramine polistirex; codeine polistirex. One supplier is listed for this compound.
Summary for chlorpheniramine polistirex; codeine polistirex
Pharmacology for chlorpheniramine polistirex; codeine polistirex

US Patents and Regulatory Information for chlorpheniramine polistirex; codeine polistirex

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fisons PENNTUSS chlorpheniramine polistirex; codeine polistirex SUSPENSION, EXTENDED RELEASE;ORAL 018928-001 Aug 14, 1985 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Vernalis R And D Ltd TUZISTRA XR chlorpheniramine polistirex; codeine polistirex SUSPENSION, EXTENDED RELEASE;ORAL 207768-001 Apr 30, 2015 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Ucb Inc CODEPREX chlorpheniramine polistirex; codeine polistirex SUSPENSION, EXTENDED RELEASE;ORAL 021369-001 Jun 21, 2004 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Vernalis R And D Ltd TUZISTRA XR chlorpheniramine polistirex; codeine polistirex SUSPENSION, EXTENDED RELEASE;ORAL 207768-001 Apr 30, 2015 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for chlorpheniramine polistirex; codeine polistirex

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,202,537 Modified release formulations containing drug-ion exchange resin complexes ➤ Try a Free Trial
8,597,684 Modified release formulations containing drug-ion exchange resin complexes ➤ Try a Free Trial
9,549,989 Modified release formulations containing drug-ion exchange resin complexes ➤ Try a Free Trial
8,747,902 Modified release formulations containing drug-ion exchange resin complexes ➤ Try a Free Trial
9,198,864 Modified release formulations containing drug-ion exchange resin complexes ➤ Try a Free Trial
9,675,703 Modified release formulations containing drug - ion exchange resin complexes ➤ Try a Free Trial
9,522,191 Modified release formulations containing drug--ion exchange resin complexes ➤ Try a Free Trial
8,883,217 Modified release formulations containing drug-ion exchange resin complexes ➤ Try a Free Trial
8,337,890 Modified release formulations containing drug-ion exchange resin complexes ➤ Try a Free Trial
8,491,935 Modified release formulations containing drug-ion exchange resin complexes ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for chlorpheniramine polistirex; codeine polistirex

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Baxter
Federal Trade Commission
Accenture
AstraZeneca
Colorcon
McKesson
Merck
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot